Prognostic impact of CDKN2A deletion in oligodendroglioma
Publication
, Conference
Smith, V; Stevenson, K; Wieden, T; Anand, M; Desjardins, A; McLendon, R; Ashley, D; Gregory, S; Lopez, G
Published in: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
2024
Duke Scholars
Published In
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
EISSN
1554-6578
ISSN
0022-3069
Publication Date
2024
Volume
83
Issue
6
Start / End Page
441 / 442
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, V., Stevenson, K., Wieden, T., Anand, M., Desjardins, A., McLendon, R., … Lopez, G. (2024). Prognostic impact of CDKN2A deletion in oligodendroglioma. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (Vol. 83, pp. 441–442).
Smith, V., K. Stevenson, T. Wieden, M. Anand, A. Desjardins, R. McLendon, D. Ashley, S. Gregory, and G. Lopez. “Prognostic impact of CDKN2A deletion in oligodendroglioma.” In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 83:441–42, 2024.
Smith V, Stevenson K, Wieden T, Anand M, Desjardins A, McLendon R, et al. Prognostic impact of CDKN2A deletion in oligodendroglioma. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2024. p. 441–2.
Smith, V., et al. “Prognostic impact of CDKN2A deletion in oligodendroglioma.” JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, vol. 83, no. 6, 2024, pp. 441–42.
Smith V, Stevenson K, Wieden T, Anand M, Desjardins A, McLendon R, Ashley D, Gregory S, Lopez G. Prognostic impact of CDKN2A deletion in oligodendroglioma. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2024. p. 441–442.
Published In
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
EISSN
1554-6578
ISSN
0022-3069
Publication Date
2024
Volume
83
Issue
6
Start / End Page
441 / 442
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences